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the charts for three months. The results of the audits were again 
discussed in staff meetings, leading to the revision of forms that 
"had been around forever". The goal was to make the forms easier 
to complete while assuring the needed information was reproted 
efficiently. Additional meetings with the staff- helped identify 
another challenge. The staff routinely reported problems occuring 
during procedures as "variances", not realizing this was a perfect 
example of Quality hnprovement. Variances are now discussed 
monthly in staff and Quality Improvement meetings and the 
results are trended. Two of the trends identified were brought o 
the attention of the equipment manufacturer. Sharing this infor- 
mation led to the re-design of a machine clip and a warning state- 
ment about hyperlipidemia patients by the companies involved. 
These are just a few of the processes that were already in place; 
the Quality Improvement Plan ahnost wrote itself. Nurses identify 
and solve problems every day. Each time this is done, the quality 
of the practice is improved. So, Interdisciplinary Teams; START 
YOUR BINDERS. 
patient was also performed. As a result, the team developed a
BMT patient education hard cover binder. The goal of the binder 
is to provide up to date, concise, and consistent educational mate- 
rial that travels with the patient across the continuum of care. The 
information contained in the binder is available on the institution- 
al web-site in an effort to pronmte asily accessed information for 
patients and staff. The content of the binder will be incorporated 
into the orientation and continuing education of new and current 
staff. Maintaining the accuracy of the information presented is 
facilitated by the ease in which the informational pages can be 
removed and replaced. The binder is designed with an easy to fol- 
low table of contents and tabulated sections for ease of use. Con- 
tents include an overview of the BMT process, side effects of 
treatment, discharge teaching, care giver information, and outpa- 
tient care. Also included are maps of the area and hospital layout, 
a business card holder, and a glossary of terms. Funding is provid- 
ed by a volunteer endowment created for patient support. A confi- 
dential patient survey is also included, which provides the basis for 
ongoing quality process improvement. 
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One of the greatest risks for morbidity and mortality in the 
blood and marrow transplantation (BMT) patients is infection. 
The  risk is high even after engraftment, especially in those 
patients on immunosuppressive th rapy. In our BMT program we 
transplant over 500 patients per year. During the winter months 
of 2001-2002, 63 patients with documented respiratory viral 
infections were reported. Respiratory syncytial virus (RSV) 
accounted for approximately 40% of these cases. RSV is a single 
stranded RNA virus that is endemic in the community, involves 
only the respiratory tract and can remain live for up to 6 hours on 
surfaces. Ninety-four percent of viral infections found in our 
patients could be traced to community sources. The nurses and 
physicians creen for signs and symptoms of upper respiratory 
infection in the clinic prior to BMT scheduled admissions, as well 
as on our 52-bed inpatient BMT unit. A nasal wash and throat 
swab are performed and sent for viral culture and rapid viral anti- 
gen testing for any patient with positive symptoms. Admission 
may be delayed and inpatients are placed on contact isolation if 
suspicion is high or initial results positive. Visitors are also 
screened on the inpatient unit. The treatment of choice for 
patients with a positive RSV infection includes continuous or 
intermittent aerosolized ribavirin with the use of a portable hepa- 
fi ltered tent to lessen exposure of the drug to others. 
[mmunoglobulins are also used to assist the immune system to 
fight the infection. Mortality is very high in patients who develop 
pneumonia, are neutropenic or where treatment is delayed. Our 
current infection control recommendations will be presented, as 
well as aspects of the physical and psychosocial nursing care for 
this potentially life threatening diagnosis and stressful treatment 
regimen. 
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Providing and maintaining up to date patient education materi- 
als is an ongoing challenge. Solving this dilemma became an iden- 
tified Quality Process Improvement goal for the BMT nursing 
leadership team for 2002. Problems identified by the multi-disci- 
plinary team included out of date, inconsistently available, and 
poorly presented materials. Our task was to look for innovative 
ideas to challenge the way things had always been done. Current 
educational materials were reviewed by the team. A review of the 
literature and evidenced-based practice in the care of the BMT 
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Increasingly, nurses play a very important role in early recog- 
nition of signs and symptoms of "engraftment syndrome" (
which some call cytokine storm). If left untreated, it can be a 
serious and fatal complication for Blood and Marrow Trans- 
plantation (BMT) patients. At the time of engraftment, the clay 
preceding or post, many patients may show signs of this phe- 
nmneuon. The signs and symptoms can be a fever up to 40 
degrees C, rash, generalized and puhnonary edema. The respi- 
ratory symptoms can be severe and including diffuse alveolar 
hemorrhage (DAII). The  pat ient  may experience marked 
increase in oxygen needs ranging front room air to 80% non- 
rebreather  mask in a short  period; shortness of  breath,  
increased anxiety,, restlessness, hemoptysis and cough may be 
additional signs. It is critical for the BMT mtrse to understand 
and recognize the risks, as well as signs and symptoms with 
even subtle changes around this period of engraftment. The 
treatment the nurse would anticipate includes: stat high dose 
steroids, typically 500mg to 1Gin for 1-3 days, followed by a 
taper depending on the patient's condit ion; a stat dose of 
diuretic, usually furosemide; and potential antimicrobial therapy 
change. If DAH is suspected, The DAH Standard of Care 
(SOC) would be initiated. Transfer to the intensive care unit 
would occur, if intubation is needed. Topical steroids may be 
ordered for skin rash. It has been demonstrated in many 
patients that this complication may herald the early develop- 
ment of acute graft vs. host disease. The clinical nurse at the 
bedside plays an extremely important role in determining the 
outcome for them patient. 
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Rapidly evolving developments in stem cell transplantation 
(SCT) present a challenge to those who educate patients undergo- 
ing this complex therapy. A prospective study using survey meth- 
ods was performed in a 14-bed Stem Cell Transplant Unit in a 
large Midwest teaching hospital. The purpose of the study was to 
assess the learning needs of stem cell transplant (SCT) patients 
upon admission to the SCT unit and again at discharge. Change 
scores were examined to determine whether p ceptions of learn 
140 
